Pharmaceutical Executive April 26, 2024
Mike Hollan

PanOmiQ is referred to as the fasted technology of its kind by the company.

Human genome sequencing is about to get faster.

Genomic research and technology company BioAro announced that it is launching new software that is capable of real-time genomic analysis.1 PanOmiQ is billed as the fastest technology of its kind, and it will launch on May 9, 2024, at the Precision Medicine Expo in Dubai.

The technology is part of the company’s precision health inititative.

In a press release, BioAro founder and CEO Dr. Anmol S. Kapoor said, “Our team at BioAro are committed to pushing the boundaries of genomic research and technology through real-time genomic testing and analysis to provide enhanced quality of life and Healthspan. With...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma / Biotech, Precision Medicine
Karius Secures $100M to Expand Non-Invasive Pathogen Blood Test
Revolutionizing Primary Care: The Role of Pharmacogenomics and AI in Personalized Medicine
23andMe: What If …
23andMe CEO Anne Wojcicki considers taking company private
Age of Opportunity: Artificial Intelligence and the Precision Medicine Future

Share This Article